CIK: 0000882095 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 13, 2025
Total Value ($000): $1,791,467 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GLPG | GALAPAGOS NV | 16,707,477 | $578,747 | 32.3% | $27.64 | — | SPON ADR | 36315X101 |
| ACLX | ARCELLX INC | 6,720,803 | $551,778 | 30.8% | $86.39 | -16.7% | COMMON STOCK | 03940C100 |
| RCUS | ARCUS BIOSCIENCES INC | 31,424,760 | $427,377 | 23.9% | $16.13 | -35.5% | COM | 03969F109 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 4,505,391 | $115,338 | 6.4% | $19.07 | +15.0% | COM NEW | 045396207 |
| — | MERUS N V | 452,527 | $42,605 | 2.4% | $42.05 | — | COM | N5749R100 |
| TNGX | TANGO THERAPEUTICS INC | 4,854,443 | $40,777 | 2.3% | $4.64 | +45.8% | COM | 87583X109 |
| KYTX | KYVERNA THERAPEUTICS INC | 4,126,119 | $24,757 | 1.4% | $4.79 | -16.6% | COM | 501976104 |
| XLO | XILIO THERAPEUTICS INC | 9,105,451 | $7,673 | 0.4% | $0.98 | -27.2% | COM | 98422T100 |
| CYPH | LEAP THERAPEUTICS INC | 5,319,148 | $2,415 | 0.1% | $2.97 | -89.4% | COM NEW | 52187K200 |